UNSPSC 51151642: Flavoxate

This classification denotes an antimuscarinic agent with the molecular formula C24H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3E74Y80MEY, chemically known as 4h-1-benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-piperidinoethyl ester, hydrochloride but generally known as flavoxate, which bears US NIH Compound Identifier 3354. European Medicines Agency schedules Flavoxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07635MIG.

UNSPSC 51151642 Flavoxate is a Commodity code that describes pharmaceutical products for urinary tract treatment, but the recent state and local procurement activity tagged under this code does not reflect pharmaceutical purchases aligned with the code's nominal scope. Seminole County, Florida, posted an IFB in June 2026 seeking naloxone and safe drug deactivation systems — opioid-overdose response equipment and pharmaceutical waste management products — which fall outside the flavoxate category. The county's procurement, totaling 1,900 units of naloxone and 800 deactivation systems annually, is structured as a competitive fixed-fee contract with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their bids, maintain workers' compensation and commercial general liability insurance, comply with E-Verify employment eligibility verification, and obtain drug-free workplace certification. The contract carries an initial two-year term with a one-year renewal option and is potentially funded through FEMA, which imposes additional federal compliance requirements.

The code shows minimal relevant recent activity aligned with its stated pharmaceutical scope. Seminole County represents the only issuing body in the recent-opportunities block, and the solicitation itself reflects a mismatch between the UNSPSC tag and the actual goods being procured. The IFB response deadline was July 26, 2023, and the county specified no set-aside designations for disadvantaged enterprises, though vendors must demonstrate legal authorization to work in the United States. The concentration of activity in Florida and the absence of parallel opportunities elsewhere suggest that this code may see limited state and local procurement volume, or that similar purchases are tagged under different UNSPSC categories aligned with naloxone, emergency medical supplies, or pharmaceutical waste management.